Capadenoson Uses, Dosage, Side Effects and more
Capadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).
| Trade Name | Capadenoson |
| Generic | Capadenoson |
| Capadenoson Other Names | Capadenoson |
| Type | |
| Formula | C25H18ClN5O2S2 |
| Weight | Average: 520.02 Monoisotopic: 519.0590449 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
